European Journal of Pharmacology 1992: Vol 223 Index

7 Pages·1992·1.5 MB·English

European Journal of Pharmacology, 223 (1992) 211-212
© 1992 Elsevier Science Publishers B.V. All rights reserved 0014-/2929 /9$059.0 0
Author index
Abe, K., see Watanabe, Y. (223) 179 Garrick, T., Yang, H., Trauner, M., Livingston, E. and Taché, Y.
Ansari, M.S., see Kessler, R.M. (223) 105 Thyrotropin-releasing hormone analog injected into the raphe
pallidus and obscurus increases gastric contractility in rats (223)
Bakich, V., see McIntosh, C.H.S. (223) 117 75
Bell, R.L., see Kessler, R.M. (223) 105 Gewecke, M., see Wedemeyer, S. (223) 173
Besse, D., Weil-Fugazza, J., Lombard, M.-C., Butler, S.H. and Gonzalez, A.M. and Pazos, A.
Besson, J.-M. Modification of muscarinic acetylcholine receptors in the rat
Monoarthritis induces complex changes in y-, 5- and «-opioid brain following chronic immobilization stress: an autoradio-
binding sites in the superficial dorsal horn of the rat spinal cord graphic study (223) 25
(223) 123 Goodson, Jr., T., see Silbaugh, S.A. (223) 57
Besson, J.-M., see Besse, D. (223) 123
Booth, R.F.G., see Lad, N. (223) 163 Hanson, P.J., see Brown, J.F. (223) 103
Brown, J.F., Hanson, PJ. and Whittle, B.J.R. Harding, S.E., Jones, $.M., Vescovo, G., Del Monte, F. and Poole-
Nitric oxide donors increase mucus gel thickness in rat stomach Wilson, P.A.
(223) 103 Reduced contractile responses to forskolin and a cyclic AMP
Buisson-Defferier, S. and Van den Buuse, M. analogue in myocytes from failing human ventricle (223) 39
Cardiovascular effects of the 5-HT,, receptor ligand, MDL Helgren, M.C., see Klabunde, R.E. (223) 1
7300S5EF, in conscious spontaneously hypertensive rats (223) 133 Herron, D.K., see Silbaugh, S.A. (223) 57
Butler, S.H., see Besse, D. (223) 123 Hiramatsu, M., see Nabeshima, T. (223) 109
Caporali, M.G., Scotti de Carolis, A. and Popoli, P.
Ishihara, K., see Renming, X. (223) 185
N-Ethyl-carboxamide adenosine inhibits perioral dyskinesias in-
duced by sulpiride + SKF 38393 in rabbits (223) 15
Chen, G. and Cheung, D.W. Jones, S.M., see Harding, S.E. (223) 39
Pharmacological distinction of the hyperpolarization response to Junien, J.L., see Yoneda, M. (223) 197
caffeine and acetylcholine in guinea-pig coronary endothelial
cells (223) 33 Kameyama, T., see Nabeshima, T. (223) 109
Cheung, D.W., see Chen, G. (223) 33 Karaki, H., see Kim, B.K. (223) 157
Clanton, J.A., see Kessler, R.M. (223) 105 Kessler, R.M., Mason, N.S., Votaw, J.R., De Paulis, T., Clanton,
Cockerham, S.L., see Silbaugh, S.A. (223) 57 J.A., Ansari, M.S., Schmidt, D.E., Manning, R.G. and Bell, R.L.
Cordeiro, R.S.B., see Pasquale, C.P. (223) 9 Visualization of extrastriatal dopamine D, receptors in the hu-
Coric, P., see Noble, F. (223) 91 man brain (223) 105
Kim, B.K., Mitsui, M. and Karaki, H.
Del Monte, F., see Harding, S.E. (223) 39 The long-term inhibitory effect of a Ca?* channel blocker, nisol-
De Paulis, T., see Kessler, R.M. (223) 105 dipine, on cytosolic Ca?* and contraction in vascular smooth
Diaz, B.L., see Pasquale, C.P. (223) 9 muscle (223) 157
Kimber, N.D., see Klabunde, R.E. (223) 1
Endoh, M., Takanashi, M. and Norota, I. Klabunde, R.E., Kimber, N.D., Kuk, J.E., Helgren, M.C. and
Effect of (+ )-niguldipine on myocardial a,-adrenoceptors in the Férstermann, U.
rabbit (223) 143 N°-Methyl-L-arginine decreases contractility, CGMP and cAMP
in isoproterenol-stimulated rat hearts in vitro (223) |
Fadayel, G.M., see Schmidt, C.J. (223) 65 Kuk, J.E., see Klabunde, R.E. (223) 1
Fleisch, J.H., see Silbaugh, S.A. (223) 57
Férstermann, U., see Klabunde, R.E. (223) 1 Lad, N., Williams, T.J. and Booth, R.F.G.
Fournié-Zaluski, M.-C., see Noble, F. (223) 83 Neutrophil infiltration into the ischaemic/ reperfused rabbit iso-
Fournié-Zaluski, M.-C., see Noble, F. (223) 91 lated myocardium: effect of PF-5901 and cycloheximide (223) 163
Fuji, K., see Nabeshima, T. (223) 109 Laorden, M.L., see Garaulet, J.V. (223) 19
Fujita, Y., see Renming, X. (223) 185 Law, S., see McIntosh, C.H.S. (223) 117
Furspan, P.B. Lefebvre, R.A., see Smits, G.J.M. (223) 97
WAY 120,491 activates ATP-sensitive potassium channels in rat Lima, M.C.R., see Pasquale, C.P. (223) 9
tail artery (223) 201 Liu, YJ.
Effect of extracellular calcium concentration on angiotensin AT,
Garaulet, J.V., Laorden, M.L. and Milanés, M.V. receptor-mediated smooth muscle contraction and antagonism in
Influence of temperature on the effects of u-, 5- and «-opioid rabbit aorta (223) 205
receptor agonists in the guinea-pig ileum myenteric plexus (223) Livingston, E., see Garrick, T. (223) 75
19 Lombard, M.-C., see Besse, D. (223) 123
Manning, R.G., see Kessler, R.M. (223) 105 Schmidt, C.J., Fadayel, G.M., Sullivan, C.K. and Taylor, V.L.
Martins, M.A., see Pasquale, C.P. (223) 9 5-HT, receptors exert a state-dependent regulation of dopamin-
Mason, N.S., see Kessler, R.M. (223) 105 ergic function: studies with MDL 100,907 and the amphetamine
McIntosh, C.H.S., Law, S. and Bakich, V. analogue, 3,4-methylenedioxymethamphetamine (223) 65
Chronic naltrexone treatment of rats: effects on gastrointestinal Schmidt, D.E., see Kessler, R.M. (223) 105
opioid peptide content (223) 117 Scotti de Carolis, A., see Caporali, M.G. (223) 15
Milanés, M.V., see Garaulet, J.V. (223) 19 Serikawa, T., see Renming, X. (223) 185
Mitsui, M., see Kim, B.K. (223) 157 Silbaugh, S.A., Stengel, P.W., Cockerham, S.L.. Roman, C.R.,
Momiyama, T., see Renming, X. (223) 185 Saussy, Jr., D.L., Spaethe, $.M., Goodson, Jr., T., Herron, D.K.
and Fleisch, J.H.
Nabeshima, T., Hiramatsu, M., Niwa, K., Fuji, K. and Kameyama, T. Pulmonary actions of LY255283, a leukotriene B, receptor antag-
Effect of naftidrofuryl oxalate on 5-HT, receptors in mouse onist (223) 57
brain: evaluation based on quantitative autoradiography and Silva, P.M.R., see Pasquale, C.P. (223) 9
head-twitch response (223) 109 Smart, T.G., see Xie, X. (223) 193
Nagata, M. and Osumi, Y. Smits, G.J.M. and Lefebvre, R.A.
Central noradrenergic inhibition of gastric motility in rats (223) Influence of age on responsiveness of rat gastric fundus to
153 agonists and to stimulation of intrinsic nerves (223) 97
Niwa, K., see Nabeshima, T. (223) 109 Spaethe, S.M., see Silbaugh, S.A. (223) 57
Noble, F., Coric, P., Fournié-Zaluski, M.-C. and Roques, B.P. Stengel, P.W., see Silbaugh, S.A. (223) 57
Lack of physical dependence in mice after repeated systemic Sullivan, C.K., see Schmidt, C.J. (223) 65
administration of the mixed inhibitor prodrug of enkephalin-de-
grading enzymes, RB1O1 (223) 91 Taché, Y., see Garrick, T. (223) 75
Noble, F., Turcaud, S., Fournié-Zaluski, M.-C. and Roques, B.P. Taché, Y., see Yoneda, M. (223) 197
Repeated systemic administration of the mixed inhibitor of Takanashi, M., see Endoh, M. (223) 143
enkephalin-degrading enzymes, RB1O1, does not induce either Takaori, S., see Renming, X. (223) 185
antinociceptive tolerance or cross-tolerance with morphine (223) Taylor, V.L., see Schmidt, C.J. (223) 65
83 Todo, N., see Renming, X. (223) 185
Norota, I., see Endoh, M. (223) 143 Trauner, M., see Garrick, T. (223) 75
Turcaud, S., see Noble, F. (223) 83
Osumi, Y., see Nagata, M. (223) 153
Ujihara, H., see Renming, X. (223) 185
Pasquale, C.P., Silva, P.M.R., Lima, M.C.R., Diaz, B.L., Rihoux,
J.P., Vargaftig, B.B., Cordeiro, R.S.B. and Martins, M.A. Van den Buuse, M., see Buisson-Defferier, S$. (223) 133
Suppression by cetirizine of pleurisy triggered by antigen in Vargaftig, B.B., see Pasquale, C.P. (223) 9
actively sensitized rats (223) 9 Vescovo, G., see Harding, $.E. (223) 39
Pazos, A., see Gonzalez, A.M. (223) 25 Votaw, J.R., see Kessler, R.M. (223) 105
Poole-Wilson, P.A., see Harding, S.E. (223) 39
Popoli, P., see Caporali, M.G. (223) 15 Watanabe, Y., Saito, H. and Abe, K.
Effects of glycine and structurally related amino acids on genera-
Reid, A., see Sawynok, J. (223) 49 tion of long-term potentiation in rat hippocampal slices (223) 179
Renming, X., Ishihara, K., Sasa, M., Ujihara, H., Momiyama, T.., Wedemeyer, S., Roeder, T. and Gewecke, M.
Fujita, Y., Todo, N., Serikawa, T., Yamada, J. and Takaori, S. Pharmacological characterization of a 5-HT receptor in locust
Antiepileptic effects of CNK-602A, a novel thyrotropin-releasing nervous tissue (223) 173
hormone analog, on absence-like and tonic seizures of sponta- Weil-Fugazza, J., see Besse, D. (223) 123
neously epileptic rats (223) 185 Whittle, B.J.R., see Brown, J.F. (223) 103
Rihoux, J.P., see Pasquale, C.P. (223) 9 Williams, T.J., see Lad, N. (223) 163
Roeder, T., see Wedemeyer, S. (223) 173
Roman, C.R., see Silbaugh, S.A. (223) 57 Xie, X. and Smart, T.G.
Roques, B.P., see Noble, F. (223) 83 y-Hydroxybutyrate depresses monosynaptic excitatory and in-
Roques, B.P., see Noble, F. (223) 91 hibitory postsynaptic potentials in rat hippocampal slices (223)
193
Saito, H., see Watanabe, Y. (223) 179
Sasa, M., see Renming, X. (223) 185 Yamada, J., see Renming, X. (223) 185
Saussy, Jr., D.L., see Silbaugh, S.A. (223) 57 Yang, H., see Garrick, T. (223) 75
Sawynok, J. and Reid, A. Yoneda, M., Junien, J.L. and Taché, Y.
Noradrenergic mediation of spinal antinociception by 5-hydroxy- Central action of a receptor ligand, JO 1784, to suppress CRF-
tryptamine: characterization of receptor subtypes (223) 49 induced inhibition of gastric function in conscious rats (223) 197
European Journal of Pharmacology, 223 (1992) 213-217
© 1992 Elsevier Science Publishers B.V. All rights reserved 0014-/2929 /9$059.0 0
Key word index
Adenosine receptors Aorta (rat)
Dopamine D, receptors; Dopamine D, receptors; Perioral dyskine- Smooth muscle (vascular); Nisoldipine; Inhibitory effects (residual),
sia; (Rabbit) (Caporali, M.G. (223) 15) Ca?* levels (cytosolic); Ca?* channels; (Relaxation) (Kim, B.K.
(223) 157)
a-Adrenoceptor antagonists
5-HT (5-hydroxytryptamine, serotonin); Noradrenaline; Desipra- ATP
mine; 6-Hydroxydopamine (6-OHDA); Spinal antinociception K* channels; Smooth muscle (vascular); Patch clamp (Furspan, P.B.
(Sawynok, J. (223) 49) (223) 201)
a@ ,,-Adrenoceptors
Atropine
(+)-Niguldipine; Positive inotropic effect; [*H)Prazosin binding;
Raphe nuclei (medullary); Vagus; RX 77368; Thyrotropin-releasing
Ventricular myocardium (rabbit) (Endoh, M. (223) 143)
hormone (Garrick, T. (223) 75)
a -Adrenoceptors
Noradrenergic mechanisms (central); Gastric motility; Brainstem Autoradiography
(Nagata, M. (223) 153) Chronic stress; Muscarinic receptors; Supersensitivity; Hippocampus;
Striatum (Gonzalez, A.M. (223) 25)
Aging
Stomach (rat); Non-adrenergic, non-cholinergic (NANC); VIP Autoradiography (quantitative)
(vasoactive intestinal polypeptide); Nitric oxide (NO); Cholinergic Joint inflammation; Pain (chronic); Polyarthritic rat; Opioid receptor
neurons (Smits, G.J.M. (223) 97) regulation (Besse, D. (223) 123)
Airway obstruction Benzamide (substituted)
Leukotriene B,; Receptor binding; Parenchymal contraction; Dopamine D, receptors; SPECT imaging (Kessler, R.M. (223) 105)
Leukotriene B, receptor antagonists; (Guinea-pig) (Silbaugh, S.A.
(223) 57) Blood pressure
5-HT,, receptors; 5-HT,, receptor agonists; 5-HT,, receptor antag-
Alanine onists; Heart rate; MDL 73005SEF; Spontaneously hypertensive rat
Glycine; Serine; Valine; Glycine modulatory site; NMDA receptors; (SHR) (Buisson-Defferier, S. (223) 133)
Long-term potentiation; Hippocampal slices (rat) (Watanabe, Y.
(223) 179)
Brainstem
Noradrenergic mechanisms (central); a@-Adrenoceptors; Gastric
Allergen
motility (Nagata, M. (223) 153)
Cetirizine; Leucocyte recruitment; Pleurisy (rat) (Pasquale, C.P. (223)
9)
Ca**
dbcAMP Endothelial cells; Caffeine (Chen, G. (223) 33)
Forskolin; Desensitisation; Myocytes; Heart failure; (Human) (Hard-
ing, S.E. (223) 39) Angiotensin; Angiotensin AT, receptors; Efficacy (Liu, YJ. (223)
205)
Amphetamine
Dopamine synthesis; Microdialysis;s MDMA (3,4-methylenedioxy- Ca** channels
methamphetamine), 5-HT, receptors (Schmidt, C.J. (223) 65) Smooth muscle (vascular); Nisoldipine; Inhibitory effects (residual);
Ca?* levels (cytosolic); Aorta (rat); (Relaxation) (Kim, B.K. (223)
Angiotensin 157)
Angiotensin AT, receptors; Ca?*; Efficacy (Liu, YJ. (223) 205)
Caffeine
Angiotensin AT, receptors Endothelial cells; Ca** (Chen, G. (223) 33)
Angiotensin; Ca?*; Efficacy (Liu, YJ. (223) 205)
Ca?* levels (cytosolic)
Antiepileptic effect
Spontaneously epileptic rat (SER); Thyrotropin-releasing hormone Smooth muscle (vascular); Nisoldipine; Inhibitory effects (residual),
analogs; CNK-602A; Dopamine (Renming, X. (223) 185) Ca?* channels; Aorta (rat); (Relaxation) (Kim, B.K. (223) 157)
Antinociceptive tolerance Cetirizine
RB101 (mixed inhibitor of enkephalin-degrading enzymes); Mor- Allergen; Leucocyte recruitment; Pleurisy (rat) (Pasquale, C.P. (223)
phine; Cross-tolerance (Noble, F. (223) 83) 9)
214
CGP 36742 B-Endorphin
y-Hydroxybutyrate; GABA, receptors; EPSP (excitatory postsynap- Naltrexone; [Met*Jenkephalin; [Leu*]enkephalin; Gastrointestinal
tic potential); IPSP (inhibitory postsynaptic potential); Hippocampus content (McIntosh, C.H.S. (223) 117)
(Xie, X. (223) 193)
Endothelial cells
Cholinergic neurons Caffeine; Ca** (Chen, G. (223) 33)
Aging; Stomach (rat); Non-adrenergic, non-cholinergic (NANC); VIP
(vasoactive intestinal polypeptide); Nitric oxide (NO) (Smits, G.J.M. EPSP (excitatory postsynaptic potential)
(223) 97) y-Hydroxybutyrate; GABA , receptors; CGP 36742; IPSP (inhibitory
postsynaptic potential); Hippocampus (Xie, X. (223) 193)
Chronic stress
Muscarinic receptors; Autoradiography; Supersensitivity; Hippocam- Forskolin
pus; Striatum (Gonzalez, A.M. (223) 25) dbcAMP; Desensitisation; Myocytes; Heart failure; (Human) (Hard-
ing, S.E. (223) 39)
CNK-602A
Spontaneously epileptic rat (SER); Thyrotropin-releasing hormone GABA, receptors
analogs; Antiepileptic effect; Dopamine (Renming, X. (223) 185) y-Hydroxybutyrate; CGP 36742; EPSP (excitatory postsynaptic po-
tential); IPSP (inhibitory postsynaptic potential); Hippocampus (Xie,
CRF (corticotropin-releasing factor) X. (223) 193)
@ Receptor ligands; Gastric acid secretion; Gastric emptying
(Yoneda, M. (223) 197) Gastric acid secretion
o Receptor ligands; CRF (corticotropin-releasing factor); Gastric
Cross-tolerance emptying (Yoneda, M. (223) 197)
RB101 (mixed inhibitor of enkephalin-degrading enzymes); Mor-
Gastric emptying
phine; Antinociceptive tolerance (Noble, F. (223) 83)
o Receptor ligands; CRF (corticotropin-releasing factor); Gastric
DAGO ([D-Ala?,N-MePhe*,Gly 5-ol]enkephalin) acid secretion (Yoneda, M. (223) 197)
Temperature; Opioid receptors; Myenteric plexus; DPDPE ([D-
Gastric motility
Pen?,D-Pen® Jenkephalin); U-50,488H (Garaulet, J.V. (223) 19)
Noradrenergic mechanisms (central); a-Adrenoceptors; Brainstem
(Nagata, M. (223) 153)
Desensitisation
Forskolin,; dbcAMP; Myocytes; Heart failure; (Human) (Harding,
Gastric mucosa
S.E. (223) 39)
Nitric oxide (NO); Mucus (Brown, J.F. (223) 103)
Desipramine
Gastrointestinal content
5-HT (5-hydroxytryptamine, serotonin); Noradrenaline; a-Adreno- Naltrexone; [Met*Jenkephalin; [Leu* Jenkephalin; B-Endorphin (Mc-
ceptor antagonists; 6-Hydroxydopamine (6-OHDA), Spinal antinoci-
Intosh, C.H.S. (223) 117)
ception (Sawynok, J. (223) 49)
Glycine
Dopamine
Serine; Alanine; Valine; Glycine modulatory site; NMDA receptors;
Spontaneously epileptic rat (SER); Thyrotropin-releasing hormone Long-term potentiation; Hippocampal slices (rat) (Watanabe, Y.
analogs; CNK-602A; Antiepileptic effect (Renming, X. (223) 185) (223) 179)
Dopamine D, receptors Glycine modulatory site
Dopamine D, receptors; Adenosine receptors; Perioral dyskinesia; Glycine; Serine; Alanine; Valine; NMDA receptors; Long-term po-
(Rabbit) (Caporali, M.G. (223) 15) tentiation; Hippocampal slices (rat) (Watanabe, Y. (223) 179)
Dopamine D, receptors Head-twitch response
Dopamine D, receptors; Adenosine receptors; Perioral dyskinesia; Naftidrofuryl oxalate (LS-121); Quantitative autoradiography; 5-HT,
(Rabbit) (Caporali, M.G. (223) 15) receptors; 5-Hydroxytryptophan (5-HTP); (Mouse) (Nabeshima, T.
(223) 109)
Benzamide (substituted); SPECT imaging (Kessler, R.M. (223) 105)
Heart failure
Dopamine synthesis Forskolin; dbcAMP; Desensitisation; Myocytes; (Human) (Harding,
Amphetamine; Microdialysis, MDMA (3,4-methylenedioxymetham- S.E. (223) 39)
phetamine), 5-HT, receptors (Schmidt, C.J. (223) 65)
Heart rate
DPDPE ((D-Pen?,D-Pen*]enkephalin)
5-HT,, receptors; 5-HT,, receptor agonists; 5-HT,, receptor antag-
Temperature; Opioid receptors; Myenteric plexus; DAGO ((D- onists; Blood pressure; MDL 73005EF; Spontaneously hypertensive
Ala?,N-MePhe*,Gly°-ollenkephalin); U-50,488H (Garaulet, J.V. rat (SHR) (Buisson-Defferier, S. (223) 133)
(223) 19)
Hippocampal slices (rat)
EDRF (endothelium-derived relaxing factor) Glycine; Serine; Alanine; Valine; Glycine modulatory site; NMDA
Nitric oxide (NO); Nitric oxide synthase inhibition; Vasoconstriction receptors; Long-term potentiation (Watanabe, Y. (223) 179)
(Klabunde, R.E. (223) 1)
Hippocampus
Efficacy Chronic stress; Muscarinic receptors; Autoradiography; Supersensi-
Angiotensin; Angiotensin AT, receptors; Ca?* (Liu, Y.J. (223) 205) tivity; Striatum (Gonzalez, A.M. (223) 25)
y-Hydroxybutyrate; GABA, receptors; CGP 36742; EPSP (excita- Learning
tory postsynaptic potential); IPSP (inhibitory postsynaptic potential) 5-HT receptors; LSD (lysergic acid diethylamide); (Locust)
(Xie, X. (223) 193) (Wedemeyer, S. (223) 173)
5-HT (5-hydroxytryptamine, serotonin) Leucocyte recruitment
Noradrenaline; a-Adrenoceptor antagonists; Desipramine; 6-Hy- Cetirizine; Allergen; Pleurisy (rat) (Pasquale, C.P. (223) 9)
droxydopamine (6-OHDA); Spinal antinociception (Sawynok, J. (223)
49) [Leu‘ Jenkephalin
Naltrexone; [Met*]enkephalin; 8-Endorphin; Gastrointestinal con-
5-HT,, receptor agonists tent (McIntosh, C.H.S. (223) 117)
5-HT,, receptors; 5-HT,, receptor antagonists; Blood pressure;
Heart rate; MDL 73005EF; Spontaneously hypertensive rat (SHR) Leukotriene B,
(Buisson-Defferier, S. (223) 133) Receptor binding; Parenchymal contraction; Airway obstruction;
Leukotriene B, receptor antagonists; (Guinea-pig) (Silbaugh, S.A.
5-HT,, receptor antagonists (223) 57)
5-HT,, receptors; 5-HT,, receptor agonists; Blood pressure; Heart
Leukotriene B, receptor antagonists
rate; MDL 73005EF; Spontaneously hypertensive rat (SHR) (Buis-
son-Defferier, S. (223) 133) Leukotriene B,; Receptor binding; Parenchymal contraction; Airway
obstruction; (Guinea-pig) (Silbaugh, S.A. (223) 57)
5-HT receptors
Long-term potentiation
LSD (lysergic acid diethylamide); Learning; (Locust) (Wedemeyer, S.
Glycine; Serine; Alanine; Valine; Glycine modulatory site; NMDA
(223) 173)
receptors; Hippocampal slices (rat) (Watanabe, Y. (223) 179)
5-HT,, receptors LSD (lysergic acid diethylamide)
5-HT,, receptor agonists; 5-HT,, receptor antagonists; Blood pres- 5-HT receptors; Learning; (Locust) (Wedemeyer, S. (223) 173)
sure; Heart rate; MDL 7300SEF; Spontaneously hypertensive rat
(SHR) (Buisson-Defferier, S. (223) 133) MDL 7300SEF
5-HT,, receptors; 5-HT,, receptor agonists; 5-HT,, receptor antag-
5-HT, receptors onists; Blood pressure; Heart rate; Spontaneously hypertensive rat
Amphetamine; Dopamine synthesis; Microdialysis;s MDMA (3,4- (SHR) (Buisson-Defferier, S$. (223) 133)
methylenedioxymethamphetamine ) (Schmidt, C.J. (223) 65)
MDMA (3,4-methylenedioxymethamphetamine )
Naftidrofuryl oxalate (LS-121); Quantitative autoradiography; 5-Hy- Amphetamine; Dopamine synthesis; Microdialysis; 5-HT, receptors
droxytryptophan (5-HTP); Head-twitch response; (Mouse) (Nabeshi- (Schmidt, C.J. (223) 65)
ma, T. (223) 109)
[Met* enkephalin
y -Hydroxybutyrate Naltrexone; [Leu*Jenkephalin; B-Endorphin; Gastrointestinal con-
GABA, receptors; CGP 36742; EPSP (excitatory postsynaptic po- tent (McIntosh, C.H.S. (223) 117)
tential); IPSP (inhibitory postsynaptic potential); Hippocampus (Xie,
X. (223) 193) Microdialysis
Amphetamine; Dopamine synthesis;s MDMA (3,4-methylenedioxy-
6-Hydroxydopamine (6-OHDA) methamphetamine); 5-HT, receptors (Schmidt, C.J. (223) 65)
5-HT (5-hydroxytryptamine, serotonin); Noradrenaline; a-Adreno-
ceptor antagonists; Desipramine; Spinal antinociception (Sawynok, J. Morphine
(223) 49) RB101 (mixed inhibitor of enkephalin-degrading enzymes); Antinoci-
ceptive tolerance; Cross-tolerance (Noble, F. (223) 83)
§-Hydroxytryptophan (5-HTP)
RB101 (mixed inhibitor of enkephalin-degrading enzymes), Nalox-
Naftidrofuryl oxalate (LS-121); Quantitative autoradiography; 5-HT,
one; Physical dependence; (Systemic administration) (Noble, F. (223)
receptors; Head-twitch response; (Mouse) (Nabeshima, T. (223) 109)
91)
Inhibitory effects (residual)
Mucus
Smooth muscle (vascular); Nisoldipine; Ca?* levels (cytosolic); Ca?*
Nitric oxide (NO); Gastric mucosa (Brown, J.F. (223) 103)
channels; Aorta (rat); (Relaxation) (Kim, B.K. (223) 157)
Muscarinic receptors
IPSP (inhibitory postsynaptic potential) Chronic stress; Autoradiography; Supersensitivity; Hippocampus;
y-Hydroxybutyrate; GABA, receptors; CGP 36742; EPSP (excita- Striatum (Gonzalez, A.M. (223) 25)
tory postsynaptic potential); Hippocampus (Xie, X. (223) 193)
M
Joint inflammation Neutrophil-endothelial cell interaction; Myocardium (rabbit); Reper-
Pain (chronic); Polyarthritic rat; Autoradiography (quantitative), fusion injury (Lad, N. (223) 163)
Opioid receptor regulation (Besse, D. (223) 123)
Myenteric plexus
K* channels Temperature; Opioid receptors; DAGO ({(D-Ala?,N-MePhe*,Gly*-
ATP; Smooth muscle (vascular); Patch clamp (Furspan, P.B. (223) oljenkephalin); DPDPE ({D-Pen?,D-Pen*]Jenkephalin); U-50,488H
201) (Garaulet, J.V. (223) 19)
216
Myocardium (rabbit) Opioid receptors
Neutrophil-endothelial cell interaction; Reperfusion injury; Myelo- Temperature; Myenteric plexus; DAGO ((D-Ala?,N-MePhe*,Gly°-
peroxidase (Lad, N. (223) 163) oljenkephalin); DPDPE ({D-Pen?,D-Pen* enkephalin); U-50,488H
(Garaulet, J.V. (223) 19)
Myocytes
Forskolin; dbcAMP; Desensitisation; Heart failure: (Human) (Hard- Pain (chronic)
ing, S.E. (223) 39) Joint inflammation; Polyarthritic rat; Autoradiography (quantitative);
Opioid receptor regulation (Besse, D. (223) 123)
Naftidrofuryl oxalate (LS-121)
Quantitative autoradiography; 5-HT, receptors; 5-Hydroxytrypto- Parenchymal contraction
phan (5-HTP); Head-twitch response; (Mouse) (Nabeshima, T. (223) Leukotriene B,; Receptor binding; Airway obstruction; Leukotriene
109) B, receptor antagonists; (Guinea-pig) (Silbaugh, S.A. (223) 57)
Naloxone Patch clamp
RBIO1 (mixed inhibitor of enkephalin-degrading enzymes); Mor- K* channels; ATP: Smooth muscle (vascular) (Furspan, P.B. (223)
phine; Physical dependence; (Systemic administration) (Noble, F. 201)
(223) 91)
Perioral dyskinesia
Naltrexone ; Dopamine D, receptors; Dopamine D, receptors; Adenosine recep-
{Met *]enkephalin; [Leu*]enkephalin; B-Endorphin; Gastrointestinal tors; (Rabbit) (Caporali, M.G. (223) 15)
content (McIntosh, C.H.S. (223) 117)
Physical dependence
Neutrophil-endothelial cell interaction RBIOL (mixed inhibitor of enkephalin-degrading enzymes); Mor-
Myocardium (rabbit); Reperfusion injury; Myeloperoxidase (Lad, N. phine; Naloxone; (Systemic administration) (Noble, F. (223) 91)
(223) 163)
Pleurisy (rat)
( + )-Niguldipine Cetirizine; Allergen; Leucocyte recruitment (Pasquale, C.P. (223) 9)
a@,,-Adrenoceptors; Positive inotropic effect; [*H]Prazosin binding;
Ventricular myocardium (rabbit) (Endoh, M. (223) 143) Polyarthritic rat
Joint inflammation; Pain (chronic); Autoradiography (quantitative),
Nisoldipine Opioid receptor regulation (Besse, D. (223) 123)
Smooth muscle (vascular); Inhibitory effects (residual); Ca?* levels
(cytosolic); Ca?* channels; Aorta (rat); (Relaxation) (Kim, B.K. (223) Positive inotropic effect
157) (+ )-Niguldipine; a, ,-Adrenoceptors; [*H]Prazosin binding; Ventric-
ular myocardium (rabbit) (Endoh, M. (223) 143)
Nitric oxide (NO)
EDRF (endothelium-derived relaxing factor); Nitric oxide synthase (7H) Prazosin binding
inhibition; Vasoconstriction (Klabunde, R.E. (223) 1) (+ )-Niguldipine; a,,-Adrenoceptors; Positive inotropic effect; Ven-
tricular myocardium (rabbit) (Endoh, M. (223) 143)
Aging; Stomach (rat); Non-adrenergic, non-cholinergic (NANC); VIP
(vasoactive intestinal polypeptide); Cholinergic neurons (Smits, Quantitative autoradiography
G.J.M. (223) 97) Naftidrofuryl oxalate (LS-121); 5-HT, receptors; 5-Hydroxytryp-
tophan (5-HTP); Head-twitch response; (Mouse) (Nabeshima, T.
Mucus; Gastric mucosa (Brown, J.F. (223) 103) (223) 109)
Nitric oxide synthase inhibition Raphe nuclei (medullary)
EDRF (endothelium-derived relaxing factor); Nitric oxide (NO); Vagus; Atropine; RX 77368; Thyrotropin-releasing hormone (Gar-
Vasoconstriction (Klabunde, R.E. (223) 1) rick, T. (223) 75)
NMDA receptors RB101 (mixed inhibitor of enkephalin-degrading enzymes)
Glycine; Serine; Alanine; Valine; Glycine modulatory site; Long-term Morphine; Antinociceptive tolerance; Cross-tolerance (Noble, F.
potentiation; Hippocampal slices (rat) (Watanabe, Y. (223) 179) (223) 83)
Non-adrenergic, non-cholinergic (NANC) Morphine; Naloxone; Physical dependence; (Systemic administra-
Aging; Stomach (rat); VIP (vasoactive intestinal polypeptide); Nitric tion) (Noble, F. (223) 91)
oxide (NO); Cholinergic neurons (Smits, G.J.M. (223) 97)
Receptor binding
Noradrenaline Leukotriene B,; Parenchymal contraction; Airway obstruction;
5-HT (5-hydroxytryptamine, serotonin); a-Adrenoceptor antagonists; Leukotriene B, receptor antagonists; (Guinea-pig) (Silbaugh, S.A.
Desipramine; 6-Hydroxydopamine (6-OHDA); Spinal antinocicep- (223) 57)
tion (Sawynok, J. (223) 49)
ao Receptor ligands
Noradrenergic mechanisms (central) CRF (corticotropin-releasing factor), Gastric acid secretion; Gastric
a-Adrenoceptors; Gastric motility; Brainstem (Nagata, M. (223) 153) emptying (Yoneda, M. (223) 197)
Opioid receptor regulation Reperfusion injury
Joint inflammation; Pain (chronic), Polyarthritic rat; Autoradiogra- Neutrophil-endothelial cell interaction; Myocardium (rabbit); Myelo-
phy (quantitative) (Besse, D. (223) 123) peroxidase (Lad, N. (223) 163)
RX 77368 Supersensitivity
Raphe nuclei (medullary); Vagus; Atropine; Thyrotropin-releasing Chronic stress; Muscarinic receptors; Autoradiography; Hippocam-
hormone (Garrick, T. (223) 75) pus; Striatum (Gonzalez, A.M. (223) 25)
Serine Temperature
Glycine; Alanine; Valine; Glycine modulatory site; NMDA recep- Opioid receptors; Myenteric plexus; DAGO ([D-Ala*,N-MePhe’*,
Gly*-oljenkephalin),; DPDPE ({D-Pen?,D-Pen*Jenkephalin); U-S0,
tors; Long-term potentiation; Hippocampal slices (rat) (Watanabe,
Y. (223) 179) 488H (Garaulet, J.V. (223) 19)
Smooth muscle (vascular) Thyrotropin-releasing hormone
Nisoldipine; Inhibitory effects (residual); Ca** levels (cytosolic); Raphe nuclei (medullary); Vagus; Atropine; RX 77368 (Garrick, T.
Ca?* channels; Aorta (rat); (Relaxation) (Kim, B.K. (223) 157) (223) 75)
Thyrotropin-releasing hormone analogs
K* channels; ATP; Patch clamp (Furspan, P.B. (223) 201)
Spontaneously epileptic rat (SER); CNK-602A; Antiepileptic effect:
Dopamine (Renming, X. (223) 185)
SPECT imaging
Dopamine D, receptors; Benzamide (substituted) (Kessler, R.M. U-50,488H
(223) 105) Temperature; Opioid receptors; Myenteric plexus; DAGO ({D-
Ala*,N-GlMy *e-olPjenhkepehal*in) ; DPDPE ((D-Pen?,D-PenJ®e*n -
Spinal antinociception kephalin) (Garaulet, J.V. (223) 19)
5-HT (5-hydroxytryptamine, serotonin); Noradrenaline; a-Adreno-
ceptor antagonists; Desipramine; 6-Hydroxydopamine (6-OHDA) Vagus
(Sawynok, J. (223) 49) Raphe nuclei (medullary); Atropine; RX 77368; Thyrotropin-releas-
ing hormone (Garrick, T. (223) 75)
Spontaneously epileptic rat (SER)
Thyrotropin-releasing hormone analogs; CNK-602A; Antiepileptic Valine
effect; Dopamine (Renming, X. (223) 185) Glycine; Serine; Alanine; Glycine modulatory site; NMDA receptors;
Long-term potentiation; Hippocampal slices (rat) (Watanabe, Y.
Spontaneously hypertensive rat (SHR) (223) 179)
5-HT,, receptors; 5-HT,, receptor agonists; 5-HT,, receptor antag-
Vasoconstriction
onists; Blood pressure; Heart rate; MDL 7300S5EF (Buisson-
Defferier, S. (223) 133) EDRF (endothelium-derived relaxing factor); Nitric oxide (NO);
Nitric oxide synthase inhibition (Klabunde, R.E. (223) 1)
Stomach (rat)
Ventricular myocardium (rabbit)
Aging; Non-adrenergic, non-cholinergic (NANC), VIP (vasoactive
(+)-Niguldipine; a,,-Adrenoceptors; Positive inotropic effect;
intestinal polypeptide); Nitric oxide (NO); Cholinergic neurons [*H]Prazosin binding (Endoh, M. (223) 143)
(Smits, G.J.M. (223) 97)
VIP (vasoactive intestinal polypeptide)
Striatum Aging; Stomach (rat); Non-adrenergic, non-cholinergic (NANC), Ni-
Chronic stress; Muscarinic receptors; Autoradiography; Supersensi- tric oxide (NO); Cholinergic neurons (Smits, G.J.M. (223) 97)
tivity; Hippocampus (Gonzalez, A.M. (223) 25)